Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hidradenitis suppurativa: A comprehensive review
Ali Alikhan, Peter Lynch, Daniel B. Eisen
Journal of the American Academy of Dermatology (2009) Vol. 60, Iss. 4, pp. 539-561
Closed Access | Times Cited: 660

Showing 1-25 of 660 citing articles:

Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
Dennis L. Stevens, Alan L. Bisno, Henry F. Chambers, et al.
Clinical Infectious Diseases (2014) Vol. 59, Iss. 2, pp. e10-e52
Closed Access | Times Cited: 2388
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
Christos C. Zouboulis, Nemesha Desai, Lennart Emtestam, et al.
Journal of the European Academy of Dermatology and Venereology (2015) Vol. 29, Iss. 4, pp. 619-644
Open Access | Times Cited: 980
Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β
Hessel H. van der Zee, L de Ruiter, D.G. van den Broecke, et al.
British Journal of Dermatology (2011) Vol. 164, Iss. 6, pp. 1292-1298
Open Access | Times Cited: 443
Hidradenitis suppurativa
Robert Sabat, Gregor B. E. Jemec, Łukasz Matusiak, et al.
Nature Reviews Disease Primers (2020) Vol. 6, Iss. 1
Closed Access | Times Cited: 419
Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa
Alexa B. Kimball, Francisco A. Kerdel, David R. Adams, et al.
Annals of Internal Medicine (2012) Vol. 157, Iss. 12, pp. 846-846
Closed Access | Times Cited: 394
Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa
Christoph Schlapbach, Tanja Hänni, Nikhil Yawalkar, et al.
Journal of the American Academy of Dermatology (2011) Vol. 65, Iss. 4, pp. 790-798
Closed Access | Times Cited: 392
Incidence of Hidradenitis Suppurativa and Associated Factors: A Population-Based Study of Olmsted County, Minnesota
Benjamin G. Vazquez, Ali Alikhan, Amy L. Weaver, et al.
Journal of Investigative Dermatology (2012) Vol. 133, Iss. 1, pp. 97-103
Open Access | Times Cited: 384
Hidradenitis Suppurativa/Acne Inversa: Criteria for Diagnosis, Severity Assessment, Classification and Disease Evaluation
Christos C. Zouboulis, V. del Mármol, Ulrich Mrowietz, et al.
Dermatology (2015) Vol. 231, Iss. 2, pp. 184-190
Closed Access | Times Cited: 324
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations
Ali Alikhan, Christopher Sayed, Afsáneh Alavi, et al.
Journal of the American Academy of Dermatology (2019) Vol. 81, Iss. 1, pp. 76-90
Open Access | Times Cited: 298
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations
Ali Alikhan, Christopher Sayed, Afsáneh Alavi, et al.
Journal of the American Academy of Dermatology (2019) Vol. 81, Iss. 1, pp. 91-101
Open Access | Times Cited: 295
Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life
Tien V. Nguyen, Giovanni Damiani, Lauren A.V. Orenstein, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 35, Iss. 1, pp. 50-61
Closed Access | Times Cited: 273
Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: A chart-verified case-control analysis
Julia Shlyankevich, Allison J. Chen, Grace E. Kim, et al.
Journal of the American Academy of Dermatology (2014) Vol. 71, Iss. 6, pp. 1144-1150
Closed Access | Times Cited: 272
Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa
G. Kelly, Rosalind Hughes, Trudy McGarry, et al.
British Journal of Dermatology (2015) Vol. 173, Iss. 6, pp. 1431-1439
Open Access | Times Cited: 267
Increased Prevalence of Metabolic Syndrome in Patients with Acne Inversa
Robert Sabat, Akewit Chanwangpong, Sylke Schneider‐Burrus, et al.
PLoS ONE (2012) Vol. 7, Iss. 2, pp. e31810-e31810
Open Access | Times Cited: 236
Identification of Three Hidradenitis Suppurativa Phenotypes: Latent Class Analysis of a Cross-Sectional Study
Florence Canouï‐Poitrine, Aurélie Le Thuaut, J. Revuz, et al.
Journal of Investigative Dermatology (2012) Vol. 133, Iss. 6, pp. 1506-1511
Open Access | Times Cited: 222
Pathophysiology of hidradenitis suppurativa: An update
Errol P. Prens, Inge E. Deckers
Journal of the American Academy of Dermatology (2015) Vol. 73, Iss. 5, pp. S8-S11
Closed Access | Times Cited: 210
Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment
Maddalena Napolitano, Matteo Megna, Elena Timoshchuk, et al.
Clinical Cosmetic and Investigational Dermatology (2017) Vol. Volume 10, pp. 105-115
Open Access | Times Cited: 208
Hidradenitis Suppurativa Is Characterized by Dysregulation of the Th17:Treg Cell Axis, Which Is Corrected by Anti-TNF Therapy
Barry Moran, Cheryl Sweeney, Rosalind Hughes, et al.
Journal of Investigative Dermatology (2017) Vol. 137, Iss. 11, pp. 2389-2395
Open Access | Times Cited: 195
Recurrence of hidradenitis suppurativa after surgical management: A systematic review and meta-analysis
Ali Mehdizadeh, Paul G. Hazen, Falk G. Bechara, et al.
Journal of the American Academy of Dermatology (2015) Vol. 73, Iss. 5, pp. S70-S77
Closed Access | Times Cited: 188
Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum
J.L. Blok, K. Li, Carrie Brodmerkel, et al.
British Journal of Dermatology (2015) Vol. 174, Iss. 4, pp. 839-846
Closed Access | Times Cited: 182
S2k guideline for the treatment of hidradenitis suppurativa / acne inversa – Short version
Christos C. Zouboulis, Falk G. Bechara, Klaus Fritz, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 6, pp. 868-889
Closed Access | Times Cited: 22
Deficiency of IL-22 Contributes to a Chronic Inflammatory Disease: Pathogenetic Mechanisms in Acne Inversa
Kerstin Wolk, Katarzyna Warszawska, Conny Hoeflich, et al.
The Journal of Immunology (2010) Vol. 186, Iss. 2, pp. 1228-1239
Open Access | Times Cited: 244
Comorbidities of hidradenitis suppurativa (acne inversa)
Sabine Fimmel, Christos C. Zouboulis
Dermato-Endocrinology (2010) Vol. 2, Iss. 1, pp. 9-16
Open Access | Times Cited: 229
Hidradenitis suppurativa markedly decreases quality of life and professional activity
Łukasz Matusiak, Andrzej Bieniek, Jacek C. Szepietowski
Journal of the American Academy of Dermatology (2010) Vol. 62, Iss. 4, pp. 706-708.e1
Open Access | Times Cited: 227
Deroofing: A tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions
Hessel H. van der Zee, Errol P. Prens, Jurr Boer
Journal of the American Academy of Dermatology (2010) Vol. 63, Iss. 3, pp. 475-480
Open Access | Times Cited: 210
Page 1 - Next Page

Scroll to top